Alvotech and Dr Reddy’s collaborate on biosimilar AVT03 EP News Bureau May 22, 2024 Dr Reddy’s gets exclusive commercialisation rights of denosumab in the US as well as semi-exclusive rights in Europe and UK
After sartans and ranitidine, where will NDMA show up next? Viveka Roychowdhury Nov 1, 2019 While regulators and pharma companies try to understand if it is the product or the process that is at fault in the ranitidine…
